p-Aminobenzoate synthase (PABS) catalyzes the conversion of chorismate and glutamine to an intermediate compound, probably 4-amino-4-deoxychorismate, which is then converted to p-aminobenzoate (PABA) by a second enzyme, aminodeoxychorismate lyase (18, 25) . The two subunits of PABS are encoded by two unlinked genes in Escherichia coli: pabB, at 40 min (10, 24) , encodes the larger 54,000-molecular-weight subunit, i.e., component I, that catalyzes the synthesis of aminodeoxychorismate from chorismate and NH3 (7, 21) ; and pabA, at 74 min (9, 10) , encodes a 21,000-molecular-weight glutamine amidotransferase subunit, i.e., component II, that allows PABS to use glutamine as the source of NH3 (12) . pabC, which encodes aminodeoxychorismate lyase, is unlinked to either pabA or pabB (8) .
PABA is essential for the biosynthesis of dihydrofolate, which in various forms participates in the synthesis of purines, thymidylate, N-formylmethionyl-tRNA, methionine, glycine, and pantothenate. As the folate moiety is not consumed during the reactions, de novo synthesis requirements for dihydrofolate and its precursors are small. Also, since exogenous folates cannot be transported and used by E. coli, dihydrofolate synthesis is essential, but only at a replenishment level as a cell grows and divides. Despite the fact that most of the enzymes involved in the biosynthesis of tetrahydrofolate have been characterized in E. coli (5) , only two genes, besides the aforementioned pabA and pabB genes, have been mapped. These are folA, which encodes dihydrofolate reductase and maps at 1 min (4, 5), andfolC, which encodes the bifunctional folylpoly--y-glutamate synthetase-dihydrofolate synthetase and maps at 56 min (3) .
Nucleotide sequence analysis of the pabA region from E. coli and Salmonella typhimurium revealed at least four closely linked genes near pabA (Fig. 1) . The gene previously designated utu (22) has been identified and designated rot (15) and encodes peptidylprolyl cis-trans isomerase (rotamase). A short open reading frame (orfl) overlaps a ShineDalgarno sequence (19) , an ATG triplet, and eight nucleo- * tides (not including the termination codon) of fic. The fic coding region extends for 200 codons and encodes a product thought to be involved in cell division (13, 14) . Thefic coding region ends 31 nucleotides upstream of pabA. Eighty-five nucleotides downstream of pabA is an open reading frame that is conserved in S. typhimurium and Klebsiella aerogenes. The conserved open reading frame is designated dtu and is likely to encode argD (13, 14) .
Transcriptional analysis of the E. coli pabA region has defined four promoter-containing regions (22) . The relative strengths of these promoters, designated Pr, P2, P1, and Pd, are 10:1:1:3 (22) . rot is preceded by a strong promoter and followed by a transcription terminator (22) . P2 lies between rot and orfl, and P1 lies partially within fic and initiates transcription 22 bp upstream of pabA. We have shown previously by RNase protection and primer extension that the 5'-terminal segment of pabA is transcribed from both P1 and P2 (22) . Deletion of P2 or insertion of a polar kanamycin cassette between P2 and P1 blocked transcription of the pabA segment from P2, as assayed by RNase protection and primer extension, but did not affect expression of a pabAlacZ translational fusion. Deletion of five nucleotides from the -10 region of P1 resulted in a 50-fold decrease in the expression of the pabA-lacZ fusion. This level of expression was not appreciably altered by the presence or absence of the polar insertion between P2 and P1. Further, strains containing the P1 deletion and wild-type pabA demonstrated a requirement for PABA. These data indicated that mRNA derived from P2 was not competent for pabA-lacZ translation and that the majority of pabA expression was derived from mRNA transcribed from P1.
The fic-pabA intergenic region contains a sequence capable of forming a stable secondary structure (AG' = -8.5) which, if formed in mRNA, would include the pabA ribosome binding site. P1 transcription initiates within the putative structure-forming sequence, and no mRNA structure occluding the pabA ribosome binding site could be formed. The formation of such a structure within the fic-pabA intergenic region was hypothesized to inhibit pabA expression from P2 mRNA at the level of translation initiation (11) . In this work, we have investigated growth conditions that might affect pabA expression and have investigated the role (-10) , the site of initiation from P1 (+ 1), and the putative pabA ribosome binding sequence (*).
of the putative secondary structure in the expression of pabA from promoter P2.
MATERIALS AND METHODS
Strains, media, and genetic techniques. All bacterial strains, plasmids, and phages are described in Table 1 . E. coli cultures were grown at 37°C with aeration either in NZY broth (16) or in Vogel-Bonner minimal salt medium (23 ucts were ethanol precipitated and eluted from 1.2% lowmelting-point agarose gel (16) . The eluted DNA was sequenced by using the primer BPNO03 and the Sequenase kit purchased from United States Biochemical Corp. Transcription analysis. RNA was isolated from mid-log cultures grown with aeration in NZY broth by the hot phenol method as modified by Arps and Winkler (1) and was followed by DNase treatment (RQ1 DNase; Promega Biotec) to remove residual contaminating DNA. RNase protection mapping was performed as described elsewhere (2 Digestion products were electrophoresed on 5% polyacrylamide-7 M urea sequencing gels and analyzed by autoradiography. Sequencing reactions of M13mpl8 were loaded on the same gel to approximate the size of protected fragments.
Oligonucleotide-directed mutagenesis. Uracil-containing DNA template of phage mpt4 was prepared from E. coli CJ236 (dut ung) and mutagenized (2) by using synthetic primers. Mutations were verified by DNA sequence analysis. The mutated inserts were transferred onto plasmid pT40Bal213 by in vivo homologous recombination as follows: (i) E. coli JM103 was infected with phage containing the mutated insert; (ii) strains harboring the phage were then transformed with pT40Bal213, and Apr colonies were selected; (iii) the Apr transformants were grown up in NZY broth containing ampicillin for about 5 h, after which time they were plated onto NZY agar plates containing ampicillin and kanamycin; and (iv) plasmid DNA from the Apr and Kanr transformants was prepared for DNA restriction analysis, which showed that the DNA preparation contained both recombinant and nonrecombinant plasmids and phage DNA. To separate recombinant plasmids from nonrecombinant plasmids and phage DNA, the DNA preparation was retransformed into E. coli MC1000 recA, and Apr Knr transformants were selected. Restriction analysis of plasmid DNA prepared from these transformants indicated the presence of only the recombinant plasmids.
Enzyme assays. P-Galactosidase activity was measured as described by Miller (17) . Mid-log cultures (25 ml) were harvested, washed with 0.85% NaCl, and resuspended in 1 ml of Z buffer. The cell suspension was sonicated for 30 s, cooled on ice for 30 s, and sonicated for an additional 30 s. Cell debris was removed from the lysate by centrifugation.
The lysate was immediately assayed for protein by the Bio-Rad method with BSA as a standard and for P-galactosi- To test the effect of PABA limitation on the expression of pabA, E. coli BN151 was grown in minimal medium supplemented with PABA (5 ng/ml) to 20 Klett units. The culture was centrifuged, and the cells were resuspended in 0.85% NaCl. A portion of the culture was saved for ,B-galactosidase assay, and two other portions were used to inoculate fresh medium either without PABA or with PABA at 10 ng/ml. The growth of each culture was monitored turbidimetrically. After 4 h of growth (70 Klett units), the PABA-supplemented culture was harvested for 3-galactosidase assay. After 6 h of incubation, growth of the unsupplemented culture reached a plateau; after 9 h (60 Klett units), it was harvested. The data presented in Table 2 show that there were no significant differences in P-galactosidase produced by each of the three cultures, indicating that the pabA-lacZ fusion was not induced by PABA limitation.
To test whether pabA expression from either P1 or P2 was affected by growth in media with different carbon sources or was affected by different growth rates, E. coli BN185 (P1l AP2) and E. coli BN198 (AP1 P2k) were grown in the presence of either glucose plus Casamino Acids (Difco), glucose alone, glycerol, or succinate, and P-galactosidase production was determined. Table 2 shows that ,3-galactosidase expression was not significantly affected, suggesting that neither growth rate control nor catabolite repression affected pabA expression from either P1 or P2.
Since pabA encodes one of the subunits of PABS, we tested the effects of overproduction of each subunit separately on the expression of the pabA-lacZ fusion. pSZD51 and pSZD52 overproduce wild-type products of pabA and pabB, respectively, but the pab promoters and ribosome binding sites have been replaced by sequences that function at a high level (18) . containing pabA and pabB genes with wild-type expression signals did not affect ,-galactosidase expression when present in BN151. These data suggest that the expression of pabA is not coordinated by an excess of one of the enzyme subunits and also indicate that the wild-type genes do not titrate a trans-acting factor involved in pabA expression.
Analysis of 3' termini of pabA mRNA. Previous results (22) indicated that the 5' segment ofpabA is transcribed from two different promoters P1 (initiating near pabA) and P2 (initiating upstream of fic). However, a pabA-lacZ fusion protein was effectively expressed only from mRNA transcribed from P1 (22; Table 2 ). To determine the extent of transcription from each promoter through pabA, we analyzed endpoints of transcripts within the pabA-dtu intergenic region, using RNA prepared from strains in which transcription from P1 or P2 was blocked. A 159-nucleotide Sau3AI fragment spanning most of the pabA-dtu intergenic region was cloned into the riboprobe plasmid pBS(+) and used to generate a 32P-labeled antisense RNA probe. RNA from E. coli BN503 (P1+ fic::kan) and BN502 (AP, P2+) was used to analyze the P1 and P2 transcripts, respectively. RNA from BN193 (AP1 fic::kan pabA-lacZ), containing a pabA-lacZ fusion which is not expressed because of disruption of transcription from both promoters, and yeast tRNA were used as negative controls. Figure 2A shows the presence of several minor protected RNA species present in the control lanes (lanes 3 and 4) that represent background in the experiment. Comparison of lanes 3 and 4 also shows that no RNA 5' termini arose from within the pabA-dtu intergenic region when that region was removed from the 5 complicated the analysis. Full-length protection and three partially protected signals were generated by using RNA from E. coli BN503 (containing mRNA transcribed from P1) (Fig. 2A, lane 1) , but these signals were absent or greatly reduced when RNA from BN503 (containing mRNA transcribed from P2) was used. The protected fragments must represent the 3' termini of the P1 mRNA, and the deduced endpoints are indicated in Fig. 2B . The pabA-dtu intergenic region does not contain any obvious secondary structures that may serve as rho-independent transcription terminators but is rather rich in thymidine, suggesting that transcription termination of the P1 transcript is probably mediated by Rho factor. That no 3' ends of the P2 mRNA were detected in this experiment supported the earlier suggestion that transcription from the P2 promoter does not proceed to the 3' end of pabA, possibly because of polarity as the result of poor translation ofpabA. Since pabA is more efficiently translated from the P1 mRNA, the posttranscriptional events that led to the termination or degradation of the P2 mRNA are not exerted on the P1 mRNA.
Expression of a pabA-lacZ fusion in rho' and rho backgrounds was examined to determine whether polarity per se was responsible for lack of pabA expression when transcribed from the P2 promoter. The pabA-lacZ fusion from E. coli BN198 (AP1 BglII::kan) was transduced into E. coli BN75 (rho-103 trpR lacZUJ18 cysB) and the isogenic rho' strain (BN73) by generalized P1 transduction. P-Galactosidase assays of extracts derived from the two strains did not reveal a significant difference in the level of pabA-lacZ expression (data not shown), suggesting that rho-mediated polarity is not primarily responsible for the lack of expression from the P2 promoter.
Genetic selection for pabA expression from mRNA derived from promoter P2. E. coli strains lacking P1 promoter activity grew very slowly in the absence of exogenous PABA supplementation. The generation time for E. coli BN502 (AP1 P2k) was approximately 180 min, compared with approximately 60 min for BN501 (P1 P2k). We took advantage of this phenotype to select mutants that had wild-type growth rates on minimal media without PABA supplementation. E. coli BN502 was mutagenized with ethyl methanesulfonate, and colonies with wild-type growth characteristics on minimal media without PABA supplementation were selected. Mutations resulting in increased growth were identified as cis to the pabA region by P1 cotransduction of the fastgrowth phenotype with the Knr marker located at the BglII site upstream of pabA. The recipient strain was E. coli BN151, which contained a pabA-lacZ fusion and was therefore pabA. The fic-pabA intergenic region and the flanking coding regions of the cis mutants were amplified by PCR, and the PCR products were subjected to nucleotide sequence analysis.
Ten fast-growth mutant strains were obtained. Four of the mutations were not linked to the Knr marker by P1 transduction, and these mutants were not further analyzed. The remaining six mutations were cotransducible with Knr, indicating a cis configuration. Chromosomal sequence analysis of the mutants is shown in Fig. 3 . Five of the mutations were identical, containing a nucleotide change of cytidine (nucleotide -4 in Fig. 3C ) to thymidine (this mutation is designated BN502-A2), and one showed a nucleotide change of guanine (nucleotide -1 in Fig. 3C ) to adenine (designated BN502-6).
Mutation BN502-A2 mapped outside of the sequence involved in the putative secondary structure formed by the P2 mRNA and lay within the sequence corresponding to the position of the P1 -10 sequence. Since the nucleotide change would bring the new -10 sequence closer to the E. coli consensus promoter sequence, the nucleotide change probably restored promoter P1 activity, although this interpretation was not verified experimentally. (A mutation in the adjacent base also partially restored P1 function; see below.) The mutation in BN502-6 mapped within the 5' end of the putative secondary structure stem and disrupted the base pairing of the putative stem loop structure (Fig. 3C) , and this mutation was chosen for further analysis.
To measure the levels of pabA transcription and translation resulting from the BN502-6 mutation, the mutation was reconstituted on a plasmid harboring a pabA-lacZ fusion, in which P-galactosidase is expressed only from P2. M13mpt4 is an M13mpl9 derivative that contains portions of the Knr determinant, the fic-pabA intergenic region, and a portion of a pabA-lacZ fusion gene (22) . The mutations present in E. coli BN502-6 were recreated by oligonucleotide-directed mutagenesis of M13mpt4 (22) . Mutant phage were identified by DNA sequence analysis, and the mutation was transferred to a plasmid by homologous recombination. The recipient plasmid, pT4OBal213, contained portions of the Knr determinant and lacZ but was deleted for the fic-pabA intergenic segment (22) . The resulting plasmid was designated pT93. The Knr cassette blocking transcription from P2 was removed by digestion with PstI and religation, and the plasmid was designated pT94. As shown in Table 3 , mutation BN502-6 in pT63 (AP1 fic::kan) did not restore P1 promoter activity. Removing the polar Knr block, thereby allowing transcription from P2 into pabA (pT94), resulted in a 6.5-fold increase of P-galactosidase specific activity relative to the activity of a plasmid containing the wild-type intergenic region (pT55).
To test whether the increased pabA-lacZ expression was due to alteration of the DNA sequence or alteration of the putative secondary structure, a second mutation was introduced to restore the base pairing potential of the secondary structure. The compensating mutation changed a C to T at position 19 to allow formation of a stable structure (AG' = -6.7). The plasmid containing the Knr cassette blocking P2 transcription was designated pT95, and a derivative with the Knr cassette removed was designated pT96. P-Galactosidase assays of plasmids carrying the double mutation indicated that the level ofpabA-lacZ expression was reduced to about the same level as that of the plasmid containing neither mutation. These data indicated that the formation of a stable secondary structure in mRNA transcribed from P2 was responsible for inhibiting translation of pabA.
Effects of ribosome translocation into thefic-pabA intergenic region on pabA expression. The previous transcriptional analysis (22) indicated that the 5' region of pabA was transcribed to about the same steady-state level from P1 and P2. If expression from each mRNA were equivalent, then expression from mRNA originating at P2 should be as high as that from mRNA originating from P1. However, a pabA-lacZ fusion was expressed at 50-fold-higher levels from mRNA transcribed from P1 (22; Table 2 ). Destabilizing the putative secondary structure increased expression by 6.5-fold (Table  3) , which is still a factor of 7 to 8 less than the expression observed from mRNA transcribed from the P1 promoter. In an attempt to achieve full expression of a pabA-lacZ fusion from mRNA transcribed from P2, we designed mutations that would allow a ribosome to traverse the fic-pabA intercistronic region. The fic stop codon (TAG) of a P1 deletion plasmid was converted to the sense codon TAC, and a new stop codon was introduced two nucleotides upstream of the pabA initiation codon by using the oligonucleotide-directed mutagenesis system described above. Since one of the nucleotide changes (TAG to TAC) was located within the deleted P1 region, we also measured the level of P-galactosidase expression in plasmids in which transcription from P2 was blocked by a polar Knr cassette. The data are summarized in Table 4 . In the absence of P2 transcription, we observed a rather low level of P-galactosidase expression, 2.7-fold higher than in a plasmid deleted for P1. The low level of expression from plasmids deleted for P1 and in which transcription from P2 was also blocked suggested that the nucleotide change of guanine to cytidine partially restored P1 promoter activity (compare pT91 with pT55 in Table 4 ). The level of P-galactosidase expression from the P2 mRNA harboring the nucleotide change was determined by subtracting the Pl-derived expression from the total activity. As shown in Table 4 , allowing translation very close to the pabA initiation codon led to a 49-fold increase in 3-galactosidase expression from mRNA transcribed from the P2 promoter (compare pT92 with pT55 in Table 4 ). This value is about equal to the expression level of P-galactosidase expressed from the P1 promoter (22) and probably represents maximum expression of P-galactosidase from the P2 mRNA.
Three additional constructions were made to allow ribosomes to translate into the fic-pabA intergenic region, extending thefic reading frame one (pT83 and pT84), two (pT85 and pT86), and three (pT87 and pT88) additional codons. The nucleotide changes in each of the mutations altered the 5' portion of the putative secondary structure and allowed ribosome movement beyond the normalfic termination site. As in the case of the pT91 construction, P1 promoter activity was found to be partially restored at a low level, probably because of the nucleotide change in the P1 promoter. The level of I-galactosidase expression from the P2 promoter of these constructions was therefore determined as described above. Table 4 shows that allowing ribosomes to translocate for one additional codon beyond the normal fic termination site increased expression from P2 4-fold (pT84), while translation two and three additional codons past the normal fic termination site increased the level of P-galactosidase expression by 13-to 14-fold (pT86 and pT88).
These data suggest that destabilization of the putative secondary structure resulted in a 7-fold increase in 3-galactosidase expression (as represented by mutation BN502-6; see above), while a combination of putative secondary structure disruption and extension offic translation resulted in up to a 13-to 14-fold increase in P-galactosidase expression. Allowing ribosomes to translate to within two nucleotides of the pabA initiation codon allowed for a 49-fold increase in P-galactosidase expression, suggesting that an additional mechanism, possibly translational coupling, affected the expression of P-galactosidase from mRNA originating from P2 in this mutant. on October 29, 2017 by guest http://jb.asm.org/ Downloaded from monocistronic, initiating 22 nucleotides prior to the pabA initiation codon and terminating at several sites within the pabA-dtu intergenic region. mRNA transcribed from P2 was polycistronic, encoding orfl, fic, and at least the first 100 nucleotides of pabA. However, transcription did not proceed to the pabA-dtu intergenic region, and PABS component II was not expressed from mRNA initiating at P2. The lack of pabA expression from P2 was not due to premature transcription termination within pabA, since suppression of polarity in a rho strain did not lead to increased expression.
Rather, the lack of pabA expression appeared to be the result of a stable secondary structure in the fic-pabA intergenic region masking the pabA ribosome binding sequence. Disruption of the putative secondary structure allowed a 6.5-fold increase in expression of pabA from mRNA arising from P2. presumably by allowing ribosomes access to the binding sequence, while a double mutation that restored base pairing also restored the wild-type level of expression. The lack of pabA translation initiation in the wild-type condition probably resulted in either premature transcription termination within pabA or degradation of the pabA portion of the P2 transcript.
Allowing ribosomes to translate various distances into the fic-pabA intergenic region increased pabA expression to various extents. Mutations that affected the stability of the putative stem-loop structure and allowed ribosomes to translate into the intergenic region increased expression of a pabA-lacZ fusion 4-to 14-fold. Only when ribosomes were allowed to move to within two nucleotides of the pabA initiation codon was high-level expression of pabA observed from mRNA originating at P2. This may be the result of coupling translation between fic and pabA or may be the combined results of nucleotide changes that alter the stability of the putative secondary structure and the efficiency of the ribosome binding site. The role of the putative secondary structure in the fic-pabA intergenic region is likely to be twofold: to uncouple expression of pabA from fic on mRNA transcribed from promoter P2 by allowing rho-dependent transcription termination or mRNA degradation initiation within pabA, and protection offic mRNA from degradation by 3'-5' exonucleases. In this sense, the putative secondary structure replaces a specific transcription terminator. The putative structure neutralizes translation of pabA and ensures the destruction of its mRNA.
The presence of two overlapping transcripts containing pabA, the presence of an apparently stable secondary structure in the fic-pabA intergenic region, and the lack of expression of pabA from P2 mRNA led us to investigate the parameters that influence pabA expression. Since expression of a pabA-lacZ chromosomal fusion was not changed by PABA limitation, growth rate, catabolite repression, overexpression of PABS component I or II, or gene dosage of pabA and pabB, we conclude that pabA is expressed constitutively, and essentially all of the expression is from mRNA transcribed from promoter P1.
So far, none of the folate biosynthetic enzymes have been shown to be regulated by physiological conditions (3, 26) . Since folate derivatives are essential for cellular metabolism, and E. coli cannot utilize exogenous folates, it is possible that the folate biosynthetic enzymes have not evolved genetic regulatory responses to extra-or intracellular levels of folate derivatives. However, if PABA biosynthesis is regulated, this regulation may occur by genetic regulation of PABS component I or enzyme X, or it may occur only at the level of regulation of enzyme activity.
